Author

Atoya Adams

Observed name: Atoya B Adams

Observed institutions: California Pacific Medical Center, Royal Brompton Hospital, Physicians Foundation

OpenAlex ID: A5113061981

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

2022 · Peter Rossing, Stefan D. Anker, et al. · Diabetes Care · 217

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

2023 · Andrew Menzies-Gow, Michael E Wechsler, et al. · The Lancet Respiratory Medicine · 162

PDF

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

2023 · Rajiv Agarwal, Wanzhu Tu, et al. · Annals of Internal Medicine · 106

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain

2015 · Mazen M Jamal, Atoya B Adams, et al. · The American Journal of Gastroenterology · 103

Mycophenolate Mofetil in Autoimmune Hepatitis Patients Not Responsive or Intolerant to Standard Immunosuppressive Therapy

2007 · Ira Inductivo–Yu, Atoya Adams, et al. · Clinical Gastroenterology and Hepatology · 90

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection

2023 · Matthew D. Sims, Sahil Khanna, et al. · JAMA Network Open · 83

PDF

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

2022 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 38

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

2023 · Jason A Tye-Din, A James M Daveson, et al. · The Lancet. Gastroenterology & hepatology · 35

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

2023 · Deborah A. Theodore, Angela R. Branche, et al. · JAMA Network Open · 22

PDF

Characterization of Borrelia burgdorferi Isolated from Erythema Migrans Lesions: Interrelationship of Three Molecular Typing Methods

2001 · Radha Iyer, Dionysios Liveris, et al. · Journal of Clinical Microbiology · 21

Risk of COVID-19 after natural infection or vaccination

2023 · Anne-Marie Rick, Matthew B. Laurens, et al. · EBioMedicine · 18

PDF

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

2024 · Colleen S. Kraft, Matthew Sims, et al. · Infectious Diseases and Therapy · 9

PDF

SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals

2024 · Leigh H. Fisher, Jia Jin Kee, et al. · JAMA Network Open · 7

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data

2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 6

PDF

Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation

2021 · Atoya Adams, Charles Barish, et al. · Advances in Therapy · 1

PDF

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

2024 · Colleen S. Kraft, Matthew Sims, et al. · Infectious Diseases and Therapy

PDF

Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897

2023 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care

PDF

Correction to: Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation

2021 · Atoya Adams, Charles Barish, et al. · Advances in Therapy

PDF

ORIGINAL ARTICLES—LIVER, PANCREAS AND BILIARY TRACT Mycophenolate Mofetil in Autoimmune Hepatitis Patients Not Responsive or Intolerant to Standard Immunosuppressive Therapy

2007 · Atoya Adams, Robert G. Gish, et al.

Works count: 21

Citation count: 915

H-index: 11

I10-index: 11